Common over-the-counter medications used for COPD management at home
The most common over-the-counter (OTC) medications that may be used for at-home management of chronic obstructive pulmonary disease (COPD) are short-acting beta-agonist (SABA) inhalers such as albuterol (available without prescription in some regions), and expectorants such as guaifenesin. However, the clinical benefit of guaifenesin in COPD is unproven, and it is not recommended as a primary therapy for symptom control or exacerbation prevention.
The American College of Chest Physicians and Canadian Thoracic Society guidelines emphasize that inhaled bronchodilators are the mainstay of therapy, and oral or OTC agents play a limited role in evidence-based management.[1-3]
Other OTC agents, such as oral theophylline, are not recommended due to limited efficacy and increased risk of adverse effects.[2][4] Mucolytics like N-acetylcysteine are used in some countries but are not widely available OTC in the United States and have limited supporting evidence for routine use.[1][3] Antitussives and antihistamines are not recommended for COPD management.[2]
The following algorithm from the New England Journal of Medicine visually summarizes the pharmacologic approach to COPD, highlighting that first-line therapies are prescription inhaled bronchodilators, with OTC medications playing a minimal role in guideline-based care.

Figure 3. Algorithm for Pharmacotherapy in Patients with a Confirmed Diagnosis of COPD.
Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease. N Engl J Med. September 25, 2019.
Used under license from The New England Journal of Medicine.
HelpfulNot Helpful
References
1.Clinical Pharmacology of Oral Maintenance Therapies for Obstructive Lung Diseases.
Pleasants RA.
Respiratory Care. 2018;63(6):671-689. doi:10.4187/respcare.06068.
2.Chronic Obstructive Pulmonary Disease: Diagnosis and Management.
Cagle SD, Landrum LS, Kennedy AM.
American Family Physician. 2023;107(6):604-612.
3.Prevention of Acute Exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.
Criner GJ, Bourbeau J, Diekemper RL, et al.
Chest. 2015;147(4):894-942. doi:10.1378/chest.14-1676.
4.Medications for COPD: A Review of Effectiveness.
Grimes GC, Manning JL, Patel P, Via RM.
American Family Physician. 2007;76(8):1141-8.
5.Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease.
Celli BR, Wedzicha JA.
The New England Journal of Medicine. 2019;381(13):1257-1266. doi:10.1056/NEJMra1900500.
Leading Journal